Myeloma protocols (printable versions)

Archived protocols
(printable versions)

MM.55 Belantamab MafodotinPrintable version
MM.1 Bendamustine, Thalidomide and Dexamethasone (BTD)Printable version
MM.2 Bendamustine, Bortezomib and Dexamethasone (BVD)Printable version
MM.3 Bone Protection in MyelomaPrintable version
MM.4 Bortezomib (Velcade) 21 dayPrintable version
MM.5 Bortezomib (Velcade) 35 dayPrintable version
MM.6 Bortezomib (Velcade), Lenalidomide and Dexamethasone (VRD)Printable version
MM.7 Bortezomib (Velcade), Thalidomide and Dexamethasone (VTD)Printable version
MM.8 Bortezomib (Velcade), Thalidomide and Dexamethasone (VTD) 28 day cyclePrintable version
MM.39 Carfilzomib & DexamethasonePrintable version
MM.53 Carfilzomib with Pomalidomide & DexamethasonePrintable version
MM.34 CarLenDexPrintable version
MM.9 CTD - attenuatedPrintable version
MM.10 CTD - full dosePrintable version
MM.11 CyBorDex Amyloidosis protocolPrintable version
MM.12 Cyclophosphamide / Bortezomib (Velcade) / Dexamethasone (CyBorDex)Printable version
MM.28 Cyclophosphamide / Carfilzomib / Dexamethasone (CyCarDex)Printable version
MM.13 Cyclophosphamide (oral) +/- PrednisolonePrintable version
MM.32 Daratumumab MonotherapyPrintable version
MM.58 Daratumumab with Bortezomib, Cyclophosphamide and DexamethasonePrintable version
MM.56 Daratumumab with Bortezomib, Thalidomide and DexamethasonePrintable version
MM.38 Daratumumab with Lenalidomide and DexamethasonePrintable version
MM.51 Daratumumab with Pomalidomide and DexamethasonePrintable version
MM.47 Daratumumab with Velcade and DexamethasonePrintable version
MM.48 Daratumumab Rapid Rate InfusionPrintable version
MM.14 Dexamethasone - high dosePrintable version
B.36 Filgrastim - biosimilarPrintable version
MM.16 Intermediate dose Melphalan with DexamethasonePrintable version
MM.52. Isatuximab with Pomalidomide and DexamethasonePrintable version
MM.33 Ixazomib with Lenalidomide and DexamethasonePrintable version
MM.17 Lenalidomide, Cyclophosphamide and weekly DexamethasonePrintable version
MM.59 Lenalidomide MaintenancePrintable version
MM.18 Lenalidomide with DexamethasonePrintable version
MM.19 Melphalan, Bortezomib (Velcade), Prednisolone (MelBorPred)Printable version
MM.20 Melphalan +/- PrednisolonePrintable version
MM.21 Melphalan, Prednisolone and Thalidomide (MPT)Printable version
MM.31 Panobinostat/Bortezomib (Velcade)/Dexamethosone (PanBorDex)Printable version
MM.22 Pomalidomide and low dose Dexamethasone (IMNOVID)Printable version
MM.49 Pomalidomide Bortezomib and Dexamethasone (PVD) 21 day CyclePrintable version
MM.26 Siltuximab IV (Sylvant ®)Printable version
MM.23 Thalidomide +/- DexamethasonePrintable version
MM.50 VTDPACE / DTPACEPrintable version
MM.25 Z-DEXPrintable version
C-VAMPPrintable version
VADPrintable version

 

 

Return to Myeloma page
 
Return to Home page